Pharmabiz

Bristol Myers Squibb opens a new AI-powered content hub, ‘Mosaic’, in Mumbai

Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...
Pharmabiz

CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic

CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
Pharmabiz

Dimerix completes patient enrolment in ACTION3 phase 3 trial of DMX-200 to treat focal segmental glomerulosclerosis

Dimerix completes patient enrolment in ACTION3 phase 3 trial of DMX-200 to treat focal segmental glomerulosclerosis: Melbourne, Australia Tuesday, December 16, 2025, 18:00 Hrs [IS ...
Pharmabiz

US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease

US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease: Shanghai Tuesday, ...
Pharmabiz

Philips inks agreement to acquire SpectraWAVE, advancing next-generation coronary intravascular imaging and physiological assessment with AI

Amsterdam, the Netherlands Tuesday, December 16, 2025, 17:00 Hrs [IST] ...
Pharmabiz

Suraksha Diagnostics, in collaboration with Medikabazaar–United Imaging, launches uAcademy to advance radiology education

Suraksha Diagnostics, in collaboration with Medikabazaar–United Imaging, launches uAcademy to advance radiology education: Our Bureau, Mumbai Tuesday, December 16, 2025, 16:30 H ...
Pharmabiz

Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs

Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs: Our Bureau, Bengaluru Tuesday, December 16, 2025, 16:45 Hrs [IST] Senores Pharmaceuticals has entered into a defini ...
Pharmabiz

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...
Pharmabiz

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing

DPGU faculty wins Rs. 1.1 crore ICMR grant for developing advanced biomaterial for diabetic wound healing: Our Bureau, Bengaluru Tuesday, December 16, 2025, 13:50 Hrs [IST] Dnyaan ...
Pharmabiz

Gujarat Kidney and Super Speciality’s IPO to open on Monday, December 22, 2025

Gujarat Kidney and Super Speciality, a regional healthcare company located in Gujarat, announced that its initial public offering (IPO) for subscription from Monday, 22nd December, 2025, and closes on ...
Pharmabiz

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe

GENESIS Pharma to distribute and commercialize Otsuka Pharmaceutical’s donidalorsen for hereditary angioedema in Central and Eastern Europe: Athens, Greece Tuesday, December 16, ...
Pharmabiz

Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor

Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor: Hong Kong Tuesday, December 16, 2025, 14:3 ...